Differentiating celiac disease from other diseases: Difference between revisions
Usama Talib (talk | contribs) No edit summary |
|||
Line 48: | Line 48: | ||
| | | | ||
* [[Gluten-free diet]] | * [[Gluten-free diet]] | ||
* Signs of the fat-soluble [[Vitamin A|vitamins A]], [[Vitamin D|D]], E, and K deficiency | * Signs of the fat-soluble [[Vitamin A|vitamins A]], [[Vitamin D|D]], [[Vitamin E|E]], and [[Vitamin K|K]] deficiency | ||
| | | | ||
* [[HLA]]-DQ2 and/or DQ8 [[gene mutation]] | * [[HLA]]-DQ2 and/or DQ8 [[gene mutation]] | ||
* Innate responses to [[wheat proteins]] | * Innate responses to [[wheat proteins]] | ||
| | | | ||
* [[Immunoglobulin A]] (IgA) anti-tissue transglutaminase (TTG) antibody | * [[Immunoglobulin A]] (IgA) [[Tissue transglutaminase|anti-tissue transglutaminase]] (TTG) antibody | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" |Grain allergy | ! align="center" style="background:#DCDCDC;" |Grain allergy | ||
Line 96: | Line 96: | ||
** [[Infertility]] | ** [[Infertility]] | ||
| | | | ||
* Mutations in the [[cystic fibrosis | * Mutations in the [[cystic fibrosis transmembrane conductance regulator]] ([[CFTR]]) protein | ||
| | | | ||
* Elevated [[Sweat chloride test|sweat chloride]] ≥60 mmol/L | * Elevated [[Sweat chloride test|sweat chloride]] ≥60 mmol/L | ||
Line 111: | Line 111: | ||
| | | | ||
* Stool [[osmotic]] gap of >125 mOsm/kg | * Stool [[osmotic]] gap of >125 mOsm/kg | ||
* Stool pH <6 | * Stool [[pH]] <6 | ||
| | | | ||
* Avoidance of [[Dietary|dietary]]<nowiki/> [[lactose]] | * Avoidance of [[Dietary|dietary]]<nowiki/> [[lactose]] | ||
* | * Maintenance of [[nutrient]] intake | ||
* Regulation of [[calcium]] intake | * Regulation of [[calcium]] intake | ||
* Use of [[enzyme]] [[lactase]] | * Use of [[enzyme]] [[lactase]] | ||
Line 120: | Line 120: | ||
* Acquired primary [[lactase deficiency]] | * Acquired primary [[lactase deficiency]] | ||
** Adult-type [[hypolactasia]] | ** Adult-type [[hypolactasia]] | ||
** [[Lactase]] | ** Inability to produce persistent[[Lactase]] | ||
| | | | ||
* [[Lactose | * [[Hydrogen Breath Test|Lactose breath hydrogen test]] | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" |[[Crohns disease|Crohns disease]] | ! align="center" style="background:#DCDCDC;" |[[Crohns disease|Crohns disease]] | ||
Line 171: | Line 171: | ||
| | | | ||
* [[Laxatives|Laxative]] screening on a stool for: | * [[Laxatives|Laxative]] screening on a stool for: | ||
** [[Diphenolic laxatives]] (eg, [[bisacodyl]]) | ** [[Laxatives|Diphenolic laxatives]] (eg, [[bisacodyl]]) | ||
** [[Polyethylene glycol|Polyethylene glyco]]<nowiki/>l-containing [[laxatives]] | ** [[Polyethylene glycol|Polyethylene glyco]]<nowiki/>l-containing [[laxatives]] | ||
|- | |- | ||
Line 197: | Line 197: | ||
* [[Graves' disease]] | * [[Graves' disease]] | ||
* [[Hashimoto's thyroiditis|Hashimoto thyroiditis]] | * [[Hashimoto's thyroiditis|Hashimoto thyroiditis]] | ||
* Toxic adenoma | * [[Toxic Adenoma|Toxic adenoma]] | ||
| | | | ||
* [[TSH]] | * [[TSH]] | ||
Line 238: | Line 238: | ||
| | | | ||
* Postinfectious | * Postinfectious | ||
* Inflammatory | * [[Inflammatory]] | ||
| | | | ||
* [[Diagnosis|Clinical diagnosis]] | * [[Diagnosis|Clinical diagnosis]] | ||
Line 312: | Line 312: | ||
* Symptoms begin mainly after ingestion of [[lactose]] | * Symptoms begin mainly after ingestion of [[lactose]] | ||
| | | | ||
* Reduction of lactase enzyme activity or lactase | * Reduction of lactase enzyme activity or in ability to produce persistent [[lactase]] | ||
* Congenital lactase deficiency | * Congenital [[lactase deficiency]] | ||
| | | | ||
* Lactase activity assay | * [[Lactase]] activity assay | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" |Allergic enteropathy/Food protein-induced enterocolitis syndrome (FPIES) | ! align="center" style="background:#DCDCDC;" |Allergic enteropathy/Food protein-induced enterocolitis syndrome (FPIES) | ||
Line 332: | Line 332: | ||
* [[Polymorphonuclear leukocytes]] presence | * [[Polymorphonuclear leukocytes]] presence | ||
| | | | ||
* Triggered by cow | * Triggered by cow milk protein | ||
* Profuse, repetitive [[vomiting]] | * Profuse, repetitive [[vomiting]] | ||
| | | | ||
Line 490: | Line 490: | ||
* Symptomatic as long as the diet includes [[lactose]] or its [[hydrolysis]] products, [[glucose]] and [[galactose]] | * Symptomatic as long as the diet includes [[lactose]] or its [[hydrolysis]] products, [[glucose]] and [[galactose]] | ||
| | | | ||
* Mutations in solute carrier family 5, member 1 gene (''SLC5A1'', also known as ''SGLT1'') | * Mutations in solute carrier family 5, member 1 gene (''[[SLC5A1]]'', also known as ''[[SGLT1]]'') | ||
** Lead to deficiency in the intestinal sodium/glucose transporter | ** Lead to deficiency in the intestinal sodium/glucose transporter | ||
| | | |
Revision as of 15:26, 13 September 2017
Celiac disease Microchapters |
Diagnosis |
---|
Treatment |
Medical Therapy |
Case Studies |
Differentiating celiac disease from other diseases On the Web |
American Roentgen Ray Society Images of Differentiating celiac disease from other diseases |
Differentiating celiac disease from other diseases in the news |
Risk calculators and risk factors for Differentiating celiac disease from other diseases |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Celiac disease must be differentiated from other diseases presenting as chronic diarrhea. Common differentials of celiac disease include lactose intolerance, cystic fibrosis, Crohns disease, laxative overuse, hyperthyroidism and irritable bowel syndrome.
Differentiating Celiac Disease from Other Diseases
Celiac disease must be differentiated from other diseases presenting as chronic diarrhea (diarrhea for more than 2 weeks) and abdominal pain and discomfort. The table below summarizes the findings that differentiate causes of chronic diarrhea and abdominal pain:[1][2][3][4][5][6][7]
Cause | Diarrhea | Peak age of onset | History | Physical exam | Lab findings | Additional finding | Cause/Pathogenesis | Gold standard dignosis | |||
---|---|---|---|---|---|---|---|---|---|---|---|
Watery | Fatty | Weight loss | FTT | Abdominal pain | |||||||
Celiac disease | +/- | +/- | Childhood
Adult |
+ | + | + |
|
|
|
| |
Grain allergy | + | - | Childhood | + | + | + |
|
|
| ||
Cystic fibrosis | - | + | Infancy and childhood | + | + | + |
|
|
| ||
Lactose intolerance | + | - | Adult | - | - | + |
|
||||
Crohns disease | + | - | Young adults
(20th) |
+ | +/- | + |
|
|
|
|
|
Laxative overuse | + | - | After childhood | +/- | - | +/- |
|
|
- |
|
|
Hyperthyroidism | + | - | Any age | + | - | +/- |
|
||||
Whipple disease | +/- | + | 50th | + | - | + |
|
| |||
Irritable bowel syndrome | + | - | Between 30 and 50 | - | - | + |
|
- |
|
| |
VIPoma | + | - | Between 30 and 50 | + | +/- | +/- |
|
|
|
| |
Gastrinoma (Zollinger-Ellison syndrome) | + | - | Between the ages of 20 and 50 | + | +/- | + |
|
|
| ||
Lactose intolerance | - | + | Any age | + | - | +/- |
|
|
|
| |
Allergic enteropathy/Food protein-induced enterocolitis syndrome (FPIES) | + | - | Infancy | +/- | +/- | + | Stool examination:
|
|
|
| |
Eosinophilic gastroenteritis | + | - | 30th | +/- | +/- | + |
|
|
| ||
Primary bile acid malabsorption | + | +/- | Childhood Adolescents | + | + | +/- | - |
|
|
|
|
Abetalipoproteinemia | - | + | Infancy | + | + | + |
|
|
|
|
|
Microscopic colitis | + | - | 60th | + | - | + |
|
|
|
| |
Congenital chloride diarrhea | + | - | Neonate | + | + | - | - |
|
Mutations in the SLC26A3 gene
|
||
Congenital sodium diarrhea | + | - | Neonate | + | + | - | - | Stool examination: |
|
|
Clinical |
Glucose-galactose malabsorption | + | - | Infancy | + | +/- | + | Stool examination:
|
|
References
- ↑ Silverberg MS, Satsangi J, Ahmad T, Arnott ID, Bernstein CN, Brant SR; et al. (2005). "Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology". Can J Gastroenterol. 19 Suppl A: 5A–36A. PMID 16151544.
- ↑ Sauter GH, Moussavian AC, Meyer G, Steitz HO, Parhofer KG, Jüngst D (2002). "Bowel habits and bile acid malabsorption in the months after cholecystectomy". Am J Gastroenterol. 97 (7): 1732–5. doi:10.1111/j.1572-0241.2002.05779.x. PMID 12135027.
- ↑ Maiuri L, Raia V, Potter J, Swallow D, Ho MW, Fiocca R; et al. (1991). "Mosaic pattern of lactase expression by villous enterocytes in human adult-type hypolactasia". Gastroenterology. 100 (2): 359–69. PMID 1702075.
- ↑ RUBIN CE, BRANDBORG LL, PHELPS PC, TAYLOR HC (1960). "Studies of celiac disease. I. The apparent identical and specific nature of the duodenal and proximal jejunal lesion in celiac disease and idiopathic sprue". Gastroenterology. 38: 28–49. PMID 14439871.
- ↑ Hertzler SR, Savaiano DA (1996). "Colonic adaptation to daily lactose feeding in lactose maldigesters reduces lactose intolerance". Am J Clin Nutr. 64 (2): 232–6. PMID 8694025.
- ↑ Briet F, Pochart P, Marteau P, Flourie B, Arrigoni E, Rambaud JC (1997). "Improved clinical tolerance to chronic lactose ingestion in subjects with lactose intolerance: a placebo effect?". Gut. 41 (5): 632–5. PMC 1891556. PMID 9414969.
- ↑ BLACK-SCHAFFER B (1949). "The tinctoral demonstration of a glycoprotein in Whipple's disease". Proc Soc Exp Biol Med. 72 (1): 225–7. PMID 15391722.